Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 987.65
+3.05 (0.31%)
Oct 17, 2025, 3:29 PM IST
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 993.81 billion as of October 17, 2025. Its market cap has decreased by -7.57% in one year.
Market Cap
993.81B
Enterprise Value
993.67B
Revenue
236.08B
Ranking
n/a
PE Ratio
21.73
Stock Price
987.65
Market Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 993.81B, an increase of 12,025.83%. That is a compound annual growth rate of 22.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 993.81B | 1.64% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | 488.07B | 87.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,980.50B |
| Divi's Laboratories | 1,752.23B |
| Cipla | 1,267.71B |
| Apollo Hospitals Enterprise | 1,126.34B |
| Mankind Pharma | 1,013.45B |
| Fortis Healthcare | 826.87B |
| Alkem Laboratories | 660.48B |
| Aurobindo Pharma | 642.54B |